InsiderTradesSIGMA

PicksTOP Companies Executives Performance Blog Topics

InsidersTradesSigma

InsiderTradesSIGMA

Multi-market insider intelligence. Official public filings, re-aggregated and scored. Private beta.

FRUSDEGBCHCAITESNLBENOSEFIDKAUATIEBRINJP+ 8 markets

Recommendations
Companies
Insiders
Performance
Backtest
Compare

Methodology
How it works
Glossary
API docs
Status
Blog

Sign in
Create account
Portfolio
API keys
Alerts
Upgrade

Privacy
Terms
Cookies
Contact
About

Built in Paris. Public sources across 28 markets: AMF France, SEC EDGAR Form 4 US, BaFin Germany, SIX SER Switzerland, RNS United Kingdom, SEDI Canada, Consob Italy, CNMV Spain, AFM Netherlands, FSMA Belgium, Oslo Bors Norway, Nasdaq Helsinki, Nasdaq Copenhagen, ASX Australia, FMA Austria, CVM Brazil, HKEX Hong Kong, BSE-Sofia Bulgaria, Tadawul Saudi Arabia, DART South Korea, EDINET Japan, SSE and SZSE China, SEBI India, KNF Poland, PSE Philippines, NZX New Zealand, JSE South Africa. Prices + fundamentals via Yahoo Finance, STOXX 600 sector ETFs (iShares Xetra). Stack: Next.js 16, Prisma, Vercel. Live out-of-sample tracker since 2026-05-16. Methodology audits: /methodologie and /docs/method-review/.

Sources: official public filings under MAR Art.19 (EU and EEA), SEC Section 16 / Form 4 (US), Art.56 SESTA (CH, SIX SER), NI 55-104 / SEDI (CA), Corporations Act s205G (AU) and equivalent regimes. Signals on this site are for educational use only and do not constitute investment advice within the meaning of MiFID II / SEC Reg-IA. Past performance does not guarantee future results. Swiss SIX SER filings are anonymised by law (role only, no name).

Theme: dark (range regime detected on CAC40 90d · as of 2026-05-22)

© 2026 Insiders TradesΣ·Private beta·Hosted on Vercel

All systems operational

InsidersTradesSigma

Sridhar Bharadwaj — personal trades · 15 reports

← Executives ★ Sign in to follow

SB

Sridhar Bharadwaj

ININ·SEBI (PIT + SAST)

JB Chemicals & Pharmaceuticals Limited

Cumul. flow

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Discover the complete record of transactions filed by Sridhar Bharadwaj. Officer active across 1 companies, notably JB Chemicals & Pharmaceuticals Limited. Cumulatively, 15 reports have been published. The latest transaction was filed on 1 December 2025 — Sale. Regulator: SEBI (PIT + SAST). All data is openly available.

Declarations15 total

Executives●SaleJJB Chemicals & Pharmaceuticals Limited0SEBI

S

Sridhar Bharadwaj

€271,16416,000 shares@ €16.9478

Equity Shares

SEBI:c0f1b76c9545a4393328beffeba47e437a42eb94·1 Dec 2025

Executives●PledgeJJB Chemicals & Pharmaceuticals Limited0SEBI

S

Sridhar Bharadwaj

€300,91417,648 shares@ €17.0509

Equity Shares

SEBI:8f32193665f6f5588b3ac738a9be27b1c7acfb94·19 Aug 2025

Executives●PurchaseJJB Chemicals & Pharmaceuticals Limited0SEBI

S

Sridhar Bharadwaj

€292,05417,648 shares@ €16.5488

Equity Shares

SEBI:d08f814883589c14185ab19044cd24bac39434c8·9 Aug 2025

Ideal exit: 6 May 2026 (T+270)

Executives●SaleJJB Chemicals & Pharmaceuticals Limited0SEBI

S

Sridhar Bharadwaj

€5,222300 shares@ €17.4074

Equity Shares

SEBI:855ec93b25caffa2fc93820903c5dff3274e8c43·6 Jun 2025

Executives●PledgeJJB Chemicals & Pharmaceuticals Limited0SEBI

S

Sridhar Bharadwaj

€5,222300 shares@ €17.4074

Equity Shares

SEBI:694fc9478939a41ae4709a2aad0719e5c863cdc8·6 Jun 2025

Executives●SaleJJB Chemicals & Pharmaceuticals Limited0SEBI

S

Sridhar Bharadwaj

€14,564828 shares@ €17.5895

Equity Shares

SEBI:349a3048e8a899a077d5bba83fb9e0e6170092cf·20 May 2025

Executives●PledgeJJB Chemicals & Pharmaceuticals Limited0SEBI

S

Sridhar Bharadwaj

€14,564828 shares@ €17.5895

Equity Shares

SEBI:ee3b5a0f479c52cc5abac6612bdd0a0beb45b070·20 May 2025

Executives●SaleJJB Chemicals & Pharmaceuticals Limited0SEBI

S

Sridhar Bharadwaj

€62,6233,000 shares@ €20.8744

Equity Shares

SEBI:75b9619728f46dfa04a8e268bff174d406e75887·23 Sept 2024

Executives●PledgeJJB Chemicals & Pharmaceuticals Limited0SEBI

S

Sridhar Bharadwaj

€62,6233,000 shares@ €20.8744

Equity Shares

SEBI:b0417c7cf1698396b9b1a276cc0fb8ba535b4e3a·23 Sept 2024

Executives●PledgeJJB Chemicals & Pharmaceuticals Limited0SEBI

S

Sridhar Bharadwaj

€80,3914,000 shares@ €20.0979

Equity Shares

SEBI:aa57e6d9010291136509abfec038eb357cc8094f·19 Sept 2024

Executives●PurchaseJJB Chemicals & Pharmaceuticals Limited0SEBI

S

Sridhar Bharadwaj

€82,7644,000 shares@ €20.691

Equity Shares

SEBI:b204e97c44c3d15a928b40d2fc84a2a4f90b7ab8·13 Sept 2024

Ideal exit: 10 Jun 2025 (T+270)

Executives●SaleJJB Chemicals & Pharmaceuticals Limited0SEBI

S

Sridhar Bharadwaj

€35,2351,598 shares@ €22.0495

Equity Shares

SEBI:62228b6c1379632c53ea55f1ace36d86c6396737·30 Dec 2022

Executives●PledgeJJB Chemicals & Pharmaceuticals Limited0SEBI

S

Sridhar Bharadwaj

€35,2351,598 shares@ €22.0495

Equity Shares

SEBI:528aed42f55c75f677891a70efe5a13b5c4f821d·30 Dec 2022

Executives●PledgeJJB Chemicals & Pharmaceuticals Limited0SEBI

S

Sridhar Bharadwaj

€45,0711,850 shares@ €24.3626

Equity Shares

SEBI:2890ddd5e53a937d02ebbb4bb36de08f7b9d58e2·28 Nov 2022

Executives●PurchaseJJB Chemicals & Pharmaceuticals Limited0SEBI

S

Sridhar Bharadwaj

€44,5591,850 shares@ €24.0857

Equity Shares

SEBI:d3f7ff4b5d52221580fe87fe8bb3657f61607255·17 Nov 2022

Ideal exit: 14 Aug 2023 (T+270)

15 of 15 declarations